Degradation of high affinity HuD targets releases Kv1.1 mRNA from miR-129 repression by mTORC1

Natasha M Sosanya1, Peggy P C Huang, Luisa P Cacheaux

  • 1Center for Learning and Memory, Section of Neurobiology, University of Texas at Austin, Austin, TX 78712, USA.

Insights

This study reveals how neuron excitability changes by regulating Kv1.1 ion channel expression. It uncovers a novel mechanism involving mTORC1 kinase, miR-129, and HuD protein controlling Kv1.1 mRNA translation.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Neuronal intrinsic excitability is crucial for brain function.
  • Mechanisms of activity-dependent regulation of ion channel expression remain largely unknown.
  • The role of mTORC1 signaling in neuronal plasticity is increasingly recognized.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying site-specific changes in intrinsic excitability.
  • To investigate the regulation of voltage-gated potassium channel Kv1.1 mRNA translation.
  • To identify key regulatory factors involved in neuronal activity-dependent plasticity.

Main Methods:

  • Investigated the interaction between mTORC1 kinase, miR-129, and HuD protein.
  • Analyzed the translational regulation of Kv1.1 mRNA.
  • Studied the impact of mTORC1 inhibition on mRNA stability and protein binding.

Main Results:

  • mTORC1 kinase activity inversely regulates Kv1.1 mRNA translation via miR-129 and HuD.
  • miR-129 represses Kv1.1 mRNA translation when mTORC1 is active.
  • HuD protein promotes Kv1.1 mRNA translation when mTORC1 is inactive.
  • mTORC1 inhibition leads to degradation of HuD target mRNAs, freeing HuD to bind Kv1.1 mRNA.

Conclusions:

  • mTORC1 signaling regulates neuronal excitability through bidirectional control of Kv1.1 ion channel expression.
  • mRNA stability and HuD-dependent translation are key mediators of this regulation.
  • This provides a novel mechanism for activity-dependent neuronal plasticity.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...